- ￥549 - 4063
- MedChemExpress(MCE)
- 美国
- HY-13260A
- 2025年12月05日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件：
4°C, sealed storage, away from moisture
- 库存：
货期：1-2天
- 供应商：
MedChemExpress LLC
- CAS号：
2453324-32-6
- 规格：
1 mg/5 mg/10 mg/25 mg/50 mg
| 规格： | 1 mg | 产品价格： | ￥549.0 |
|---|---|---|---|
| 规格： | 5 mg | 产品价格： | ￥975.0 |
| 规格： | 10 mg | 产品价格： | ￥1560.0 |
| 规格： | 25 mg | 产品价格： | ￥2725.0 |
| 规格： | 50 mg | 产品价格： | ￥4063.0 |
MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。
CCT128930 hydrochloride
CAS No. : 2453324-32-6
MCE 国际站：CCT128930 hydrochloride
产品活性：CCT128930 hydrochloride是一种有效且选择性的 AKT 抑制剂 (IC50=6 nM)。CCT128930 hydrochloride 通过靶向 AKT 的 Met282 (PKA-AKT 嵌合体的 Met173)，对 PKA 激酶 (IC50=168 nM) 具有 28 倍的选择性，对 p70S6K (IC50=120 nM) 具有 20 倍的选择性。具有抗肿瘤活性。
研究领域：PI3K/Akt/mTOR | Autophagy | Apoptosis
作用靶点：Akt | Autophagy | Apoptosis
In Vitro: The GI50 values of CCT128930 hydrochloride for growth inhibition are 6.3 μM for U87MG human glioblastoma cells, 0.35 μM for LNCaP human prostate cancer cells, and 1.9 μM for PC3 human prostate cancer cells, all of which are PTEN-deficient human tumor cell lines.
CCT128930 (0.1-60 μM; 1 hour; U87MG human glioblastoma cells) hydrochloride shows an initial induction of AKT phosphorylation at serine 473 up to 20 μM, followed by a decreased in phosphorylation at higher concentrations.
CCT128930 hydrochloride inhibits direct substrates of AKT (Ser9 GSK3β, pThr246 PRAS40 and pT24 FOXO1/p32 FOXO3a) at ≥5 μM, and the downstream target, pSer235/236 S6RP at ≥10 μM, with generally constant levels of the respective total proteins and GAPDH.
CCT128930 (18.9 μM; U87MG human glioblastoma cells) hydrochloride causes an increase in phosphorylation of pSer473 AKT after 30 minutes, which is sustained for 48 hours. Total AKT protein signal decreases gradually from 8 hours to 48 hours of treatment.
CCT128930 (PTEN-null U87MG human glioblastoma cells; over a 24-hour time period) hydrochloride results in an increase in G0/G1 phase cells from 43.6% to 64.8% after 24 hours of treatment.
CCT128930 (0-10 μM; 24 hours) hydrochloride increases, but not inhibites, the phosphorylation of Akt in HepG2 and A549 cells. CCT128930 (0-20 μM; 24 hours) hydrochloride inhibits cell proliferation by inducing cell cycle arrest in G1 phase through downregulation of cyclinD1 and Cdc25A, and upregulation of p21, p27 and p53. CCT128930 (20 μM) hydrochloride triggers cell apoptosis with activation of caspase-3, caspase-9, and PARP. CCT128930 (0-20 μM; 24 hours) hydrochloride increases phosphorylation of ERK and JNK in HepG2 cells. CCT128930 (0-20 μM; 24 hours) hydrochloride activates DNA damage response of HepG2 cell characterized by phosphorylation of H2AX, ATM (ataxia-telangiectasia mutated), Chk1 and Chk2.
In Vivo: CCT128930 (25 or 40 mg/kg; i.p. daily or twice daily for 5 days) hydrochloride shows antitumor activities in U87MG and BT474 human breast cancer xenografts.Summary of the pharmacokinetic parameters of CCT128930 (25 mg/kg) in CrTacNCr-Fox1nu mice
| Tissue | Route | T1/2 (h) |
Tmax (h) |
Cmax (μM) |
Vss (L) |
Cl (L/h) |
AUC0-∞ (µMh) |
Bioavailability (%) |
| Plasma | i.v. | 0.95 | 0.083 | 6.36 | 0.25 | 0.325 | 4.62 | 100 |
| Plasma | i.p. | 2.33 | 0.5 | 1.28 | N/A | 0.372 | 1.33 | 28.8 |
| Tumor | i.p. | 3.89 | 1 | 8.02 | N/A | 0.06* | 25.8 | N/A |
| Plasma | p.o. | 0.57 | 0.5 | 0.432 | N/A | 0.317 | 0.392 | 8.5 |
*Apparent clearance.
相关产品：Bioactive Compound Library Plus | Apoptosis Compound Library | Kinase Inhibitor Library | PI3K/Akt/mTOR Compound Library | Stem Cell Signaling Compound Library | Anti-Cancer Compound Library | Autophagy Compound Library | Anti-Aging Compound Library | Differentiation Inducing Compound Library | Oxygen Sensing Compound Library | Glycolysis Compound Library | Cytoskeleton Compound Library | Glutamine Metabolism Compound Library | Anti-Breast Cancer Compound Library | Anti-Lung Cancer Compound Library | Anti-Pancreatic Cancer Compound Library | Anti-Blood Cancer Compound Library | Anti-Cancer Metabolism Compound Library | Anti-Obesity Compound Library | Angiogenesis-Related Compound Library | Glucose Metabolism Compound Library | Anti-Liver Cancer Compound Library | Anti-Colorectal Cancer Compound Library | Anti-Prostate Cancer Compound Library | Anti-Pulmonary Fibrosis Compound Library | Cancer Stem Cells Compound Library | Heterocyclic Compound Library | Pain-Related Compound Library | Membrane Protein-targeted Compound Library | Highly Selective Inhibitors Library | Highly Selective Activators Library | Cell Death Library | Serine/Threonine Kinase Inhibitor Library | MG-132 | Doxorubicin hydrochloride | Bafilomycin A1 | LY294002 | Tamoxifen | Paclitaxel | Y-27632 | Acetylcysteine | Angiotensin II human | 2-Deoxy-D-glucose | Staurosporine | SB-431542 | Actinomycin D | Deferoxamine mesylate | Bortezomib | 5-Fluorouracil | Trametinib | Sorafenib | Oxaliplatin | Gemcitabine | Temozolomide | Rotenone | Mdivi-1 | Elesclomol | Ruxolitinib | Decitabine | SP600125 | MK-2206 dihydrochloride | Etoposide | Monomethyl auristatin E
热门产品线：重组蛋白 | 化合物库 | 天然产物 | 荧光染料 | PROTAC | 同位素标记物
Trending products：Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Dye Reagents | PROTAC | Isotope-Labeled Compounds
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验！ zhibinx2007 现在比较常用的有两种，可以用AZD235或BEZ8055。 寂寞小美鱼 目前有应用于临床的靶向药物吗？ selleckchem01 可以用于小胶质细胞的有：MK-2206；AT7867；CCT128930； 已经用于临床试验的有MK-2206 现给大家介绍一下主要的AKT抑制剂： MK-2206：a highly selective, potent
pET28,30,24,49(KAN+) T7 T7 Ter pET32(a,b,c)(AMP+) T7/S.tag T7 Ter pET50(amp+) T7/s.tag T7TER pET44(AMP+) T7/s.tag T7 Ter pEYFP-N1 pEGFP-N-5’ pEGFP-N-3’ pEYFP-C1 pEGFP-C-5’ pEGFP-C-3' pFLAG-CMV pFLAG-CMV -F pFLAG-CMV -R pGAD424 GAL4 AD 3'AD
Wnt/β-catenin信号通路在实验性大鼠肝癌形成过程中的作用
只大鼠在造模过程中死亡，其余32只分别在喂药后第1、4、6、8、10、12、14、16周，处死动物，每次处死4 只。每只取不同部位的小块肝组织，分别置于40 g /L 多聚甲醛固定液中固定并液氮冻存。正常对照组8只，不给药。 1. 2. 2 wn t1、β-catenin、APC、cyc lin D1 及c-m yc mRNA 的RT-PCR 检测 引物的设计和合成交由大连宝信生物公司完成，经验证后使用。 扩增wn t1 基因的引物序列为: 5-ATCCTG
技术资料暂无技术资料 索取技术资料
